|
⚲
|
| Keyboard |
| King John C
✚
|
|
|---|---|
| CIK # | 0001738190 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001738190] | |
| 4 | [0001738190] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| King John C | |
| Ra Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Ra Pharmaceuticals Inc RARX
Stock Option (Right to Buy) · derivative
|
2020-04-02 | Disposed to issuer | 107,000 | $0.00 | |
|
Ra Pharmaceuticals Inc RARX
Stock Option (Right to Buy) · derivative
|
2020-04-02 | Disposed to issuer | 190,000 | $0.00 | |
|
Ra Pharmaceuticals Inc RARX
Common Stock
|
2020-04-02 | Disposed to issuer | 10,823 | $48.00 | 519,504 |
|
Ra Pharmaceuticals Inc RARX
Restricted Stock Units · derivative
|
2020-04-02 | Disposed to issuer | 30,658 | $0.00 | |
|
Ra Pharmaceuticals Inc RARX
Restricted Stock Units · derivative
|
2019-04-16 | Option exercise | 15,329 | $0.00 | |
|
Ra Pharmaceuticals Inc RARX
Common Stock
|
2019-04-16 | Option exercise | 15,329 | ||
|
Ra Pharmaceuticals Inc RARX
Common Stock
|
2019-04-16 | Tax withheld | 4,506 | $21.93 | 98,817 |
|
Ra Pharmaceuticals Inc RARX
Options to Purchase Common Stock · derivative
|
2019-02-01 | Grant | 107,000 | $0.00 | |
|
Ra Pharmaceuticals Inc RARX
Option to Purchase Common Stock · derivative
|
2018-05-01 | Grant | 190,000 | $0.00 | |
|
Ra Pharmaceuticals Inc RARX
Restricted Stock Units · derivative
|
2018-05-01 | Grant | 45,987 | $0.00 |